X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-17 | MRNA | Afeyan Noubar | Dir | S - Sale | $103.38 | -15,000 | 11,722,969 | 0% | -$1,550,703 | ||||||
2024-04-15 | MRNA | Hoge Stephen | Pres | S - Sale | $105.02 | -15,000 | 1,642,290 | -1% | -$1,575,300 | ||||||
2024-04-10 | MRNA | Afeyan Noubar | Dir | S - Sale | $107.12 | -15,000 | 11,737,969 | 0% | -$1,606,865 | ||||||
| D | 2024-04-08 | MRNA | Mock James M | CFO | S - Sale+OE | $101.93 | -705 | 5,048 | -12% | -$71,859 | |||||
2024-04-03 | MRNA | Afeyan Noubar | Dir | S - Sale | $101.69 | -15,000 | 11,752,969 | 0% | -$1,525,268 | ||||||
2024-03-27 | MRNA | Afeyan Noubar | Dir | S - Sale | $109.06 | -15,000 | 11,767,969 | 0% | -$1,635,864 | ||||||
2024-03-20 | MRNA | Afeyan Noubar | Dir | S - Sale | $102.39 | -15,000 | 11,782,969 | 0% | -$1,535,820 | ||||||
2024-03-15 | MRNA | Hoge Stephen | Pres | S - Sale | $103.17 | -15,000 | 1,657,290 | -1% | -$1,547,550 | ||||||
2024-03-13 | MRNA | Afeyan Noubar | Dir | S - Sale | $108.54 | -15,000 | 11,797,969 | 0% | -$1,628,031 | ||||||
| D | 2024-03-08 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $99.05 | -544 | 9,267 | -6% | -$53,884 | |||||
| D | 2024-03-04 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $94.34 | -117 | 8,673 | -1% | -$11,038 | |||||
| D | 2024-03-04 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $94.34 | -309 | 1,672,290 | 0% | -$29,151 | |||||
| D | 2024-02-29 | MRNA | Mock James M | CFO | S - Sale+OE | $94.57 | -647 | 4,300 | -13% | -$61,188 | |||||
| D | 2024-02-29 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $94.57 | -670 | 8,557 | -7% | -$63,363 | |||||
| D | 2024-02-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $94.57 | -2,388 | 1,671,947 | 0% | -$225,838 | |||||
2024-02-22 | MRNA | Hoge Stephen | Pres | S - Sale | $100.00 | -15,000 | 1,669,482 | -1% | -$1,500,000 | ||||||
2024-02-16 | MRNA | Hoge Stephen | Pres | S - Sale | $88.88 | -10,542 | 1,684,482 | -1% | -$936,981 | ||||||
2024-02-16 | MRNA | Bancel Stephane | CEO | S - Sale | $88.88 | -26,351 | 21,075,476 | 0% | -$2,342,098 | ||||||
| D | 2024-02-12 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $86.23 | -304 | 1,672,330 | 0% | -$26,214 | |||||
2024-01-16 | MRNA | Hoge Stephen | Pres | S - Sale | $103.90 | -15,000 | 1,672,112 | -1% | -$1,558,500 | ||||||
| D | 2024-01-08 | MRNA | Mock James M | CFO | S - Sale+OE | $109.76 | -772 | 3,632 | -18% | -$84,731 | |||||
2023-12-27 | MRNA | Hoge Stephen | Pres | S - Sale | $100.01 | -45,000 | 1,687,112 | -3% | -$4,500,450 | ||||||
| D | 2023-12-08 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $79.09 | -563 | 7,912 | -7% | -$44,525 | |||||
| D | 2023-12-06 | MRNA | Garay Arpa | Chief Commercial Officer | S - Sale+OE | $78.34 | -564 | 3,690 | -13% | -$44,182 | |||||
| D | 2023-12-04 | MRNA | Klinger Shannon Thyme | GC | S - Sale+OE | $79.31 | -111 | 7,336 | -1% | -$8,804 | |||||
| D | 2023-12-04 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $79.31 | -309 | 1,732,112 | 0% | -$24,508 | |||||
| D | 2023-11-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $79.81 | -1,136 | 1,731,770 | 0% | -$90,666 | |||||
| D | 2023-11-10 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $68.76 | -263 | 1,730,495 | 0% | -$18,084 | |||||
2023-11-01 | MRNA | Afeyan Noubar | Dir | S - Sale | $76.00 | -10,000 | 11,812,969 | 0% | -$760,032 | ||||||
2023-10-25 | MRNA | Afeyan Noubar | Dir | S - Sale | $76.99 | -10,000 | 11,822,969 | 0% | -$769,854 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |